In Vitro Strategies to Ensure Bioequivalence of Sustained-Release (SR) Formulations
SR formulations are designed to release the drug gradually over an extended period, making their performance highly dependent on variable GI conditions such as pH, motility, and enzymes. Therefore, a single dissolution test is insufficient. 1. MMD Testing SR formulations must release consistently across the GI tract. Dissolution is evaluated at pH 1.2 (stomach), pH…
